Skip to content
akaturk Academic measurement
Search

Article detail · 2011 · article

Efficacy of Intravenous Tranexamic Acid in Reducing Blood Loss after Elective Cesarean Section: A Prospective, Randomized, Double-Blind, Placebo-Controlled Study

ISSN0735-1631
YÖKSİS OpenAlex Top 10%
Year2011
Citations213OpenAlex
Citations205Semantic Scholar · 14 influential
Percentile%93.4
FWCI3.371.00 = world average
Scopus (SJR)Q2
WoS (JCR)Q3

Data source split

  • YÖKSİSYÖKSİS article record
  • YÖKSİS venueAmerican Journal of Perinatology
  • Catalog match (ISSN)American Journal of Perinatology
  • OpenAlexOpenAlex enrichment (abstract, citations, topics)
  • Semantic Scholarcitation count (not merged with OpenAlex)

Abstract

OpenAlex English

We sought to determine the efficacy and safety of tranexamic acid (TA) in reducing blood loss during elective cesarean section (CS). We performed a randomized, double-blind, placebo-controlled study of 660 women who underwent elective CS. The patients were randomly selected to receive an intravenous infusion of either TA (1 g/10 mL in 20 mL of 5% glucose; N = 330) or 30 mL 5% glucose prior to surgery. The primary outcome was the estimated blood loss following CS. No demographic difference was observed between groups. The mean estimated blood loss was significantly lower in women treated with TA compared with women in the placebo group (499.9 ± 206.4 mL versus 600.7 ± 215.7 mL, respectively; P < 0.001), and the proportion of women in the TA group who had an estimated blood loss >1000 mL was significantly lower than in the placebo group (7 [2.1%] versus 19 [5.8%], respectively; relative risk [RR] 2.7; 95% confidence interval [CI] 1.1 to 6.3; P < 0.03). Furthermore, more women in the placebo group than in the TA group required additional uterotonic agents (48 [14.5%] versus 28 [8.5%], respectively; RR 1.7; 95% CI 1.1 to 2.6; P = 0.02). Maternal and neonatal outcomes did not differ significantly. TA significantly reduced bleeding during CS, the percentage of patients with blood loss >1000 mL, and the need for additional uterotonic agents. Furthermore, the incidence of thromboembolic events did not increase. Our results suggest that TA can be used safely and effectively to reduce CS bleeding.

Topics

Citations

OpenAlex cited_by_count. Not a WoS or Scopus citation count; those sources have no separate column here.

213citationsOpenAlex · cited_by_count (cache / database)

4 publications in the local catalog that cite this work (OpenAlex reference match; not the full global list).

  1. 2013 Tranexamic acid for cesarean section a double blind placebo controlled randomized clinical trialCitations 109 · OpenAlex
  2. 2013 Can Intravenous Injection of Tranexamic Acid Be Used in Routine Practice with Active Management of the Third Stage of Labor in Vaginal Delivery A Randomized Controlled StudyCitations 61 · OpenAlex
  3. 2013 Can Intravenous Injection of Tranexamic Acid Be Used in Routine Practice with Active Management of the Third Stage of Labor in Vaginal Delivery? A Randomized Controlled StudyCitations 61 · OpenAlex
  4. 2018 Active management of the third stage of labor: A brief overview of key issuesCitations 30 · OpenAlex

Authors

6
  1. KEMAL GÜNGÖRDÜK 1
  2. GÖKHAN YILDIRIM 2
  3. OSMAN AŞICIOĞLU TRAKYA ÜNİVERSİTESİ 3
  4. ÖZGÜ ÇELİKKOL GÜNGÖRDÜK 4
  5. SİNEM SUDOLMUŞ 5
  6. CEMAL ARK 6